Cetera Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $26M | Buy |
935,637
+464,750
| +99% | +$12.9M | 0.2% | 102 |
|
|
2023
Q4 | $13.6M | Buy |
470,887
+155,233
| +49% | +$4.69M | 0.19% | 115 |
|
|
2023
Q3 | $10.5M | Buy |
315,654
+79,121
| +33% | +$2.8M | 0.16% | 140 |
|
|
2023
Q2 | $8.68M | Sell |
236,533
-14,212
| -6% | -$553K | 0.14% | 158 |
|
|
2023
Q1 | $10.2M | Sell |
250,745
-13,982
| -5% | -$604K | 0.17% | 131 |
|
|
2022
Q4 | $13.6M | Buy |
264,727
+34,570
| +15% | +$1.66M | 0.25% | 87 |
|
|
2022
Q3 | $10.1M | Sell |
230,157
-6,511
| -3% | -$316K | 0.27% | 86 |
|
|
2022
Q2 | $12.4M | Buy |
236,668
+4,919
| +2% | +$251K | 0.28% | 76 |
|
|
2022
Q1 | $12M | Buy |
231,749
+4,894
| +2% | +$254K | 0.24% | 91 |
|
|
2021
Q4 | $13.4M | Sell |
226,855
-18,138
| -7% | -$899K | 0.27% | 78 |
|
|
2021
Q3 | $10.5M | Buy |
244,993
+50,540
| +26% | +$2.24M | 0.21% | 103 |
|
|
2021
Q2 | $7.62M | Buy |
194,453
+2,181
| +1% | +$84.8K | 0.18% | 123 |
|
|
2021
Q1 | $6.97M | Buy |
192,272
+27,041
| +16% | +$960K | 0.19% | 111 |
|
|
2020
Q4 | $6.08M | Buy |
165,231
+11,053
| +7% | +$405K | 0.19% | 107 |
|
|
2020
Q3 | $5.37M | Buy |
154,178
+34,765
| +29% | +$1.22M | 0.2% | 104 |
|
|
2020
Q2 | $3.71M | Buy |
119,413
+6,201
| +5% | +$211K | 0.16% | 136 |
|
|
2020
Q1 | $3.51M | Sell |
113,212
-4,901
| -4% | -$167K | 0.19% | 122 |
|
|
2019
Q4 | $4.4M | Sell |
118,113
-4,855
| -4% | -$173K | 0.19% | 116 |
|
|
2019
Q3 | $4.2M | Sell |
122,968
-12,385
| -9% | -$450K | 0.19% | 119 |
|
|
2019
Q2 | $5.56M | Buy |
135,353
+8,354
| +7% | +$332K | 0.25% | 93 |
|
|
2019
Q1 | $5.11M | Buy |
126,999
+3,170
| +3% | +$127K | 0.25% | 92 |
|
|
2018
Q4 | $5.12M | Buy |
123,829
+4,342
| +4% | +$180K | 0.3% | 79 |
|
|
2018
Q3 | $4.99M | Buy |
119,487
+8,609
| +8% | +$331K | 0.24% | 92 |
|
|
2018
Q2 | $3.83M | Buy |
110,878
+87
| +0.1% | +$2.97K | 0.22% | 109 |
|
|
2018
Q1 | $3.74M | Buy |
110,791
+284
| +0.3% | +$9.76K | 0.23% | 113 |
|
|
2017
Q4 | $3.8M | Sell |
110,507
-323
| -0.3% | -$11K | 0.23% | 99 |
|
|
2017
Q3 | $3.76M | Sell |
110,830
-3,091
| -3% | -$99.3K | 0.23% | 105 |
|
|
2017
Q2 | $3.62M | Sell |
113,921
-5,488
| -5% | -$173K | 0.23% | 107 |
|
|
2017
Q1 | $3.87M | Buy |
119,409
+1,283
| +1% | +$40.5K | 0.26% | 90 |
|
|
2016
Q4 | $3.63M | Sell |
118,126
-15,023
| -11% | -$459K | 0.27% | 86 |
|
|
2016
Q3 | $4.28M | Sell |
133,149
-10,761
| -7% | -$360K | 0.33% | 68 |
|
|
2016
Q2 | $4.82M | Buy |
143,910
+14,750
| +11% | +$471K | 0.37% | 54 |
|
|
2016
Q1 | $3.63M | Sell |
129,160
-166
| -0.1% | -$4.74K | 0.3% | 72 |
|
|
2015
Q4 | $3.95M | Sell |
129,326
-2,921
| -2% | -$91.9K | 0.33% | 59 |
|
|
2015
Q3 | $3.93M | Sell |
132,247
-37,537
| -22% | -$1.2M | 0.37% | 55 |
|
|
2015
Q2 | $5.4M | Buy |
169,784
+7,840
| +5% | +$256K | 0.46% | 45 |
|
|
2015
Q1 | $5.34M | Buy |
161,944
+60,429
| +60% | +$1.92M | 0.49% | 37 |
|
|
2014
Q4 | $3M | Sell |
101,515
-580
| -0.6% | -$16.6K | 0.29% | 94 |
|
|
2014
Q3 | $2.87M | Buy |
102,095
+4,334
| +4% | +$122K | 0.22% | 83 |
|
|
2014
Q2 | $2.76M | Buy |
97,761
+31,532
| +48% | +$899K | 0.31% | 72 |
|
|
2014
Q1 | $2.02M | Sell |
66,229
-15,765
| -19% | -$470K | 0.28% | 79 |
|
|
2013
Q4 | $2.38M | Buy |
81,994
+9,932
| +14% | +$289K | 0.35% | 64 |
|
|
2013
Q3 | $1.96M | Buy |
72,062
+11,460
| +19% | +$312K | 0.35% | 69 |
|
|
2013
Q2 | $1.61M | Buy |
+60,602
| New | +$1.67M | 0.34% | 73 |
|
Other funds holding PFE
Cetera Advisors's PFE Position: Q1 2024 in Review
Cetera Advisors increased its Pfizer (PFE) stake by 99% in Q1 2024, buying an estimated $12.9M and bringing the position to 935,637 shares worth $26M. The position accounts for 0.2% of the portfolio, ranked #102.
Cetera Advisors first reported a position in PFE in Q2 2013 and has held it in 44 quarters since. 2,874 funds tracked by Wall St. Rank hold PFE as of Q1 2024.
- Cetera Advisors held 935,637 shares of Pfizer worth $26M as of Q1 2024.
- Cetera Advisors bought 464,750 Pfizer shares in Q1 2024, an estimated $12.9M.
- Pfizer made up 0.2% of Cetera Advisors's portfolio in Q1 2024, its #102 holding.
- Cetera Advisors first reported a position in Pfizer in Q2 2013 and has held it in 44 quarters since.
- 2,874 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.
Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.